Keyphrases
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
95%
Urokinase-type Plasminogen Activator
89%
Plasminogen Activator inhibitor-1 (PAI-1)
47%
Kallikrein-related Peptidases
44%
CD87
31%
Breast Cancer
30%
Serine Protease
28%
Ovarian Cancer
27%
Protease
26%
Tumor Tissue
25%
MRNA Expression
23%
Kallikrein-related Peptidase 4
21%
Kallikrein-related Peptidase 7
21%
MRNA Level
21%
Overexpression
20%
Urokinase
20%
Breast Cancer Patients
19%
KLK4
19%
Tumor-associated
19%
Tumor
18%
Tumor Metastasis
16%
Tumor Cells
16%
Ovarian Cancer Cells
16%
Plasminogen Activation System
15%
Triple-negative Breast Cancer
15%
Adenylate Kinase
15%
Human Tissue Kallikrein
15%
Ovarian Cancer Patients
14%
Tissue Kallikrein
13%
Tumor Growth
13%
Prognostic Biomarker
13%
Breast Cancer Cells
13%
Clinical Significance
13%
Saccharomyces Cerevisiae
13%
Amino Acids
13%
Kallikrein-related Peptidase 5
13%
Plasminogen
12%
High-grade Serous Ovarian Cancer (HGSOC)
12%
Prognostic Relevance
11%
Recombinant
11%
In Cancer
11%
Overall Survival
10%
Rab31
10%
PITX2
10%
Kallikrein-related Peptidase 6
10%
Tumor Invasion
10%
Prostate Cancer
10%
Quantitative PCR
10%
Tissue Factor
10%
Monoclonal Antibody
10%
Biochemistry, Genetics and Molecular Biology
Kallikrein
100%
Peptidase
80%
Urokinase
69%
Messenger RNA
47%
Cancer Cell
42%
Urokinase Receptor
38%
Protease
33%
Serine Protease
29%
Plasminogen Activator Inhibitor-1
27%
KLK4
17%
N-Terminus
15%
Adenylate Kinase
13%
Tumor Progression
13%
Binding Site
11%
Amino Acids
11%
Saccharomyces cerevisiae
11%
PITX2
10%
DNA Methylation
10%
Wild Type
10%
Cell Invasion
10%
Overall Survival
9%
Cell Adhesion
9%
mRNA Expression Level
9%
Promoter Region
9%
Thromboplastin
8%
KLK5
8%
Plasminogen Activation
8%
Liquid
8%
Integrin
7%
Protein Expression
7%
Peptide Sequence
7%
Cysteine Protease
7%
Cell Migration
7%
Molecular Weight
7%
Profilin
7%
KLK7
7%
Cell Proliferation
7%
Quantitative Reverse Transcription Polymerase Chain Reaction
7%
Matrix Metalloproteinase
7%
Isoform
7%
Enzyme
7%
Escherichia coli
7%
Real-Time Polymerase Chain Reaction
7%
Enzyme Activity
6%
Crystal Structure
6%
Allele
6%
Plasmid
6%
Mitochondrion
6%
Degradome
6%
Chemokine
6%
Medicine and Dentistry
Urokinase
47%
Ovarian Cancer
46%
Neoplasm
43%
Breast Cancer
30%
Plasminogen Activator Inhibitor-1
29%
Urokinase Receptor
26%
Peptidase
24%
Metastatic Carcinoma
22%
Kallikrein
22%
Cancer Cell
19%
Tumor Cell
18%
Messenger RNA
17%
In Vitro
14%
Receptor
12%
Diseases
12%
Tumor Progression
12%
Malignant Neoplasm
11%
Biological Marker
11%
Enzyme Linked Immunosorbent Assay
10%
Proteinase
9%
Tumor Invasion
9%
Serine Proteinase
9%
Cancer
9%
Cancer Therapy
9%
Plasminogen Activation
8%
Plasminogen Activator
7%
Immunohistochemistry
7%
Receptor Expression
7%
Protein Expression
7%
Tissue Kallikrein
7%
Cell Migration
6%
Cancer Biomarkers
6%
Krukenberg Tumor
6%
Integrin
6%
Primary Tumor
6%
Monoclonal Antibody
6%
Cell Invasion
6%
Cell Surface
5%
Binding Site
5%
Extracellular Matrix
5%
Protein Degradation
5%
Overall Survival
5%